International Clinical Trial: MK8527-010: MK-8527 as HIV-1 PrEP in Women

Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (PACTR202509662689795) titled 'MK8527-010: MK-8527 as HIV-1 PrEP in Women' on Sept. 10.

Study Type: Interventional

Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Central randomisation by phone/fax

Primary Sponsor: MSD Pty Ltd

Condition:

HIV/AIDS

Recruitment Status: Not Recruiting

Phase: Phase-3

Date of First Enrollment: 27/09/2025

Target Sample Size: 4580

Countries of Recruitment: South Africa South Africa South Africa South Africa South Africa South Africa South Africa South...